Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in NUVB — Nuvation Bio Inc.

CIK 886982 NEW YORK, NY
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$10,818,616
+$2,539,119 QoQ
Shares Held
1,904,686
-1.3% QoQ
Ownership
0.542%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 242 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. NUVB ranks #147 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in NUVB

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,818,616 1,904,686
2026-03-31 $8,279,497 1,929,953
2025-12-31 $15,196,276 1,696,013
2025-09-30 $4,449,678 1,202,616
2025-06-30 $2,882,184 1,478,044
2025-03-31 $1,803,335 1,024,623
2024-12-31 $5,399,197 2,029,774
2024-09-30 $3,032,348 1,324,170
2024-06-30 $3,327,356 1,139,506
2024-03-31 $4,148,966 1,139,826
2023-12-31 $1,199,102 794,108
2023-09-30 $552,819 412,553
2023-06-30 $902,693 501,497
2023-03-31 $660,913 398,141
2022-12-31 $463,007 241,150
2022-09-30 $1,219,336 544,347
2022-06-30 $469,948 145,046
2022-03-31 $3,768,499 716,445
2021-12-31 $1,248,208 146,848
2021-09-30 $544,443 54,773
2021-06-30 $1,501,972 161,329
2021-03-31 $2,302,061 220,293